Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 18

1.

Comparison of the effect of simvastatin versus simvastatin/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia.

Moutzouri E, Liberopoulos EN, Tellis CC, Milionis HJ, Tselepis AD, Elisaf MS.

Atherosclerosis. 2013 Nov;231(1):8-14. doi: 10.1016/j.atherosclerosis.2013.08.013. Epub 2013 Aug 27.

PMID:
24125402
[PubMed - in process]
2.

The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA₂.

Tellis CC, Moutzouri E, Elisaf M, Wolfert RL, Tselepis AD.

J Lipid Res. 2013 Dec;54(12):3394-402. doi: 10.1194/jlr.M041806. Epub 2013 Oct 3.

PMID:
24092915
[PubMed - in process]
3.

Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia.

Vlahos AP, Naka KK, Bechlioulis A, Theoharis P, Vakalis K, Moutzouri E, Miltiadous G, Michalis LK, Siamopoulou-Mavridou A, Elisaf M, Milionis HJ.

Pediatr Cardiol. 2014 Jan;35(1):63-70. doi: 10.1007/s00246-013-0742-0. Epub 2013 Jul 3.

PMID:
23821294
[PubMed - in process]
4.

Effect of simvastatin/ezetimibe 10/10 mg versus simvastatin 40 mg on serum vitamin D levels.

Liberopoulos EN, Makariou SE, Moutzouri E, Kostapanos MS, Challa A, Elisaf M.

J Cardiovasc Pharmacol Ther. 2013 May;18(3):229-33. doi: 10.1177/1074248412470513. Epub 2013 Jan 2.

PMID:
23288870
[PubMed - indexed for MEDLINE]
5.

Inflammatory biomarkers and cardiovascular risk assessment. Current knowledge and future perspectives.

Moutzouri E, Tsimihodimos V, Tselepis AD.

Curr Pharm Des. 2013;19(21):3827-40. Review.

PMID:
23286437
[PubMed - indexed for MEDLINE]
6.

Effects of manidipine plus rosuvastatin versus olmesartan plus rosuvastatin on markers of insulin resistance in patients with impaired fasting glucose, hypertension, and mixed dyslipidemia.

Liberopoulos EN, Moutzouri E, Rizos CV, Barkas F, Liamis G, Elisaf MS.

J Cardiovasc Pharmacol Ther. 2013 Mar;18(2):113-8. doi: 10.1177/1074248412463611. Epub 2012 Oct 31.

PMID:
23113965
[PubMed - indexed for MEDLINE]
7.

Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.

Moutzouri E, Tellis CC, Rousouli K, Liberopoulos EN, Milionis HJ, Elisaf MS, Tselepis AD.

Atherosclerosis. 2012 Dec;225(2):381-7. doi: 10.1016/j.atherosclerosis.2012.08.037. Epub 2012 Sep 24.

PMID:
23062767
[PubMed - indexed for MEDLINE]
8.

Effects of statin monotherapy versus statin plus ezetimibe combination on serum uric acid levels.

Moutzouri E, Liberopoulos EN, Florentin M, Liamis G, Elisaf MS.

J Cardiovasc Pharmacol Ther. 2013 Jan;18(1):13-8. doi: 10.1177/1074248412444463. Epub 2012 Apr 26.

PMID:
22539817
[PubMed - indexed for MEDLINE]
9.

Life-threatening hypophosphataemia in a cirrhotic patient with jaundice.

Moutzouri E, Liberopoulos EN, Elisaf M.

Arch Med Sci. 2011 Aug;7(4):736-9. doi: 10.5114/aoms.2011.24148. Epub 2011 Sep 2.

PMID:
22291814
[PubMed]
Free PMC Article
10.

Prediabetes: to treat or not to treat?

Moutzouri E, Tsimihodimos V, Rizos E, Elisaf M.

Eur J Pharmacol. 2011 Dec 15;672(1-3):9-19. doi: 10.1016/j.ejphar.2011.10.007. Epub 2011 Oct 12. Review.

PMID:
22020287
[PubMed - indexed for MEDLINE]
11.

Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.

Moutzouri E, Liberopoulos E, Mikhailidis DP, Kostapanos MS, Kei AA, Milionis H, Elisaf M.

Int J Clin Pract. 2011 Nov;65(11):1141-8. doi: 10.1111/j.1742-1241.2011.02779.x.

PMID:
21995692
[PubMed - indexed for MEDLINE]
12.

Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study.

Kei A, Elisaf M, Moutzouri E, Tsiara S, Liberopoulos E.

Int J Hypertens. 2011;2011:830434. doi: 10.4061/2011/830434. Epub 2011 May 15.

PMID:
21747984
[PubMed]
Free PMC Article
13.

Pharmaceutical Modulation of the Renin Angiotensin Aldosterone System for Stroke Prevention: A Review of Experimental and Clinical Evidence.

Moutzouri E, Ntaios G, Elisaf M, Milionis HJ.

CNS Spectr. 2010 Nov 1. pii: Moutzouri. [Epub ahead of print]

PMID:
21632010
[PubMed - as supplied by publisher]
14.

The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia.

Florentin M, Liberopoulos EN, Moutzouri E, Rizos CV, Tselepis AD, Elisaf MS.

Curr Med Res Opin. 2011 Mar;27(3):685-92. doi: 10.1185/03007995.2010.546394. Epub 2011 Jan 27.

PMID:
21271793
[PubMed - indexed for MEDLINE]
15.

Pharmaceutical modulation of the Renin Angiotensin aldosterone system for stroke prevention: a review of experimental and clinical evidence.

Moutzouri E, Daios G, Elisaf M, Milionis HJ.

CNS Spectr. 2010 Nov;15(11):619-29. doi: 10.1017/S1092852912000077.

PMID:
24726049
[PubMed - in process]
16.

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.

Moutzouri E, Kei A, Elisaf MS, Milionis HJ.

Vasc Health Risk Manag. 2010 Aug 9;6:525-39. Review.

PMID:
20730069
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Hypocholesterolemia.

Moutzouri E, Elisaf M, Liberopoulos EN.

Curr Vasc Pharmacol. 2011 Mar;9(2):200-12.

PMID:
20626336
[PubMed - indexed for MEDLINE]
18.

Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertension.

Moutzouri E, Florentin M, Elisaf MS, Mikhailidis DP, Liberopoulos EN.

Curr Vasc Pharmacol. 2010 May;8(3):344-62. Review.

PMID:
20180771
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk